Skip to main content

Biomarkers: Troponin testing--risk stratification to stratified medicine.

Publication ,  Journal Article
Newby, LK; Ohman, EM
Published in: Nat Rev Cardiol
November 2015

Among patients with diabetes mellitus and ischaemic heart disease, high-sensitivity testing effectively identified 39.3% of patients with elevated troponin levels who were at high 5-year risk of cardiovascular death, myocardial infarction, or stroke. Compared with optimal medical therapy, revascularization did not reduce ischaemic events among patients with elevated troponin levels.

Duke Scholars

Published In

Nat Rev Cardiol

DOI

EISSN

1759-5010

Publication Date

November 2015

Volume

12

Issue

11

Start / End Page

625 / 626

Location

England

Related Subject Headings

  • Sensitivity and Specificity
  • Risk Assessment
  • Myocardial Revascularization
  • Myocardial Ischemia
  • Humans
  • Diabetes Mellitus, Type 2
  • Cardiovascular System & Hematology
  • Biomarkers
  • 3201 Cardiovascular medicine and haematology
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Newby, L. K., & Ohman, E. M. (2015). Biomarkers: Troponin testing--risk stratification to stratified medicine. Nat Rev Cardiol, 12(11), 625–626. https://doi.org/10.1038/nrcardio.2015.157
Newby, L Kristin, and E Magnus Ohman. “Biomarkers: Troponin testing--risk stratification to stratified medicine.Nat Rev Cardiol 12, no. 11 (November 2015): 625–26. https://doi.org/10.1038/nrcardio.2015.157.
Newby LK, Ohman EM. Biomarkers: Troponin testing--risk stratification to stratified medicine. Nat Rev Cardiol. 2015 Nov;12(11):625–6.
Newby, L. Kristin, and E. Magnus Ohman. “Biomarkers: Troponin testing--risk stratification to stratified medicine.Nat Rev Cardiol, vol. 12, no. 11, Nov. 2015, pp. 625–26. Pubmed, doi:10.1038/nrcardio.2015.157.
Newby LK, Ohman EM. Biomarkers: Troponin testing--risk stratification to stratified medicine. Nat Rev Cardiol. 2015 Nov;12(11):625–626.

Published In

Nat Rev Cardiol

DOI

EISSN

1759-5010

Publication Date

November 2015

Volume

12

Issue

11

Start / End Page

625 / 626

Location

England

Related Subject Headings

  • Sensitivity and Specificity
  • Risk Assessment
  • Myocardial Revascularization
  • Myocardial Ischemia
  • Humans
  • Diabetes Mellitus, Type 2
  • Cardiovascular System & Hematology
  • Biomarkers
  • 3201 Cardiovascular medicine and haematology
  • 1102 Cardiorespiratory Medicine and Haematology